- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04372667
Adaptation and Evaluation of the PMTCT CSC in Dedza and Ntcheu Districts, Malawi
Adaptation and Evaluation of the PMTCT Community Score Card Approach in Dedza and Ntcheu Districts, Malawi
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prevention of Mother to Child HIV Transmission (PMTCT) services aim to identify HIV-infected pregnant and breastfeeding mothers and initiate them on antiretroviral treatment (ART) for improving the health of the mother as well as reducing HIV transmission to their infants. In 2011, Malawi was the first country to adopt lifelong ART for HIV- pregnant and breastfeeding women, known as 'Option B+'. Despite leading the way on operationalization of this approach, Malawi has faced challenges retaining HIV-infected pregnant and breastfeeding women on lifelong ART as well as with improving uptake of early infant HIV testing for HIV-exposed infants. Innovative approaches are needed which engage health service users (i.e. patients) as part of quality improvement solutions within clinical settings to improve retention throughout the PMTCT cascade and ultimately improve PMTCT outcomes for mothers and infants.
One approach to broadly engage health service users in quality improvement activities is the Community Score Card (CSC). The CSC engages both service providers and users within a clinical setting in dialogues to identify solutions to the perceived barriers with health service delivery and utilization.
CARE developed the CSC intervention in Malawi in 2002 as part of a project aimed at developing innovative and sustainable models to improve general maternal and child health services. The main goal of the CSC intervention is to positively influence the quality, efficiency, and accountability with which health services are provided at different levels. The original CSC consists of five core phases, repeated on a regular basis (called "rounds"), for the life of the project.
This project adapted the CSC to the PMTCT setting across 11 sites in two priority PEPFAR scale-up districts in Malawi. The adaptation of the CSC was evaluated through a pre-post design to measure change in maternal retention on ART, change in maternal retention across the PMTCT service cascade, and uptake of Early Infant Diagnosis (EID) services following CSC implementation. Additionally, the project estimated the cost of the adapted CSC implementation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lilongwe, Malawi
- Elizabeth Glaser Pediatric AIDS Foundation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- New born infants of HIV-positive women
- Women 18 years and over newly initiating antiretroviral therapy (ART) at ART clinic
- HIV-positive pregnant women >15 years of age newly receiving care at first ANC (ANC1)
- Women who are HIV-positive at ANC1 (known positive, already on treatment)
- Women who are newly identified HIV-positive and initiated on treatment at ANC (newly identified at ANC or labor and delivery)
- Women known HIV-positive but not yet on treatment prior to enrollment at ANC and initiated on treatment at ANC
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Post intervention
Community score card approach
|
The CSC intervention is a participatory community approach. Health care workers (HCWs), PMTCT clients identified the issues that most impacted PMTCT service quality and uptake, and came together to implement actions for improvement. The core implementation strategy is using dialogue in a participatory forum that engages both service users and service providers. The CSC consists of five core phases, repeated on a regular basis (called "rounds"), for the life of the project. The five core phases include:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Early diagnosis of HIV exposed infants (HEI)
Time Frame: 6 - 8 weeks after birth
|
Proportion of HEI receiving a DNA PCR test
|
6 - 8 weeks after birth
|
|
Early retention of pregnant and breastfeeding HIV positive women in PMTCT
Time Frame: 1 to 6 months
|
Proportions of HIV-positive pregnant and breastfeeding women (including women newly-identified and already-known to be HIV positive) retained in PMTCT services
|
1 to 6 months
|
|
Early retention of newly diagnosed HIV-positive women in HIV care
Time Frame: 1 to 6 months
|
Proportions of HIV-positive women (pregnant and breastfeeding women as well as non-pregnant women) newly initiating ART services retained in HIV care
|
1 to 6 months
|
|
Implementation cost of CSC
Time Frame: 12 months
|
Estimate the total cost of implementing of the CSC intervention at community and facility levels.
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Godfrey Woelk, PhD, E. Glaser Pediatric AIDS Found
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- EG0163
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Medical College of WisconsinCompleted
-
Emory UniversityCompleted
-
Rhode Island HospitalUnknown
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Lampiris, Harry W., M.D.AbbottUnknown
Clinical Trials on Community score card approach
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedContraceptive Usage | Unintended PregnancyKenya
-
University of AlbertaRoche Pharma AG; Institute of Health Economics, CanadaCompletedChronic Obstructive Pulmonary Disease | Pulmonary Fibrosis | Cystic Fibrosis | Pulmonary HypertensionCanada
-
International Islamic University, IslamabadPakistan Institute of Living and LearningActive, not recruitingCannabis DependencePakistan
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Institut Catala de SalutNot yet recruitingHomebound Persons | Disabled Persons | Social Isolation or LonelinessSpain
-
University of RwandaCompletedDepression | Anxiety | Post-traumatic Stress Disorder (PTSD) | Intimate Partner Violence (IPV)Rwanda
-
Texas Christian UniversityNational Institute on Drug Abuse (NIDA)Not yet recruitingDrug Overdose | Criminal Behavior | Substance Use Disorder (SUD)United States
-
Karolinska InstitutetRecruitingSubstance Use Disorders | Criminal BehaviorSweden
-
UConn HealthNational Institute on Drug Abuse (NIDA)CompletedMental Disorders | Cannabis Use Disorder | Addictive BehaviorsUnited States
-
OCHIN, Inc.University of FloridaUnknownEmergency Department Utilization | Primary Care Quality Metrics | Well Child Visits in First 15 Months of Life NQF 1392 | Diabetes Mellitus NQF 0059 | Colorectal Cancer Screening NQF 0034 | Alcohol and Drug Screening
-
University of New MexicoNational Institute on Drug Abuse (NIDA)Completed